Joep W. R. Sins
Research Subjects
Joep W. R. Sins has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Agaath Koudstaal
GGZ Delfland
1 shared publication Alfred H. van Meurs
Department of Paediatrics, Haga Hospital, the Hague, the Netherlands
1 shared publicationAndré Delannoy
Department of Haematology, Hôpital de Jolimont, Haine-St-Paul, Belgium
1 shared publicationAndré Efira
Department of Haemato-oncology, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
1 shared publicationAnita W. Rijneveld
Department of Haematology, Erasmus MC, Erasmus University Medical Centre, Rotterdam, the Netherlands
1 shared publicationAnna Vanderfaeillie
Department of Paediatrics, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium
1 shared publication
Latest Publications
- Open Access
Unraveling dynamic factors in Dialectic Behavioural Treatment for Adolescents (DBT-A): a study protocol
Dialectical Behavioural Therapy for Adolescents (DBT-A) is an effective treatment for adolescents exhibiting features of borderline personality disorder (BPD). However, some do not benefit, potentially leading to major negative outcomes later in life. Previous quantitative studies have highlighted the importance of dynamic (changeable) factors in determining treatment success, including the therapeutic alliance, emotional dynamics between therapist and adolescent, and the motivation of those involved. Nevertheless, the specific contribution of these factors to the therapeutic process and perceived treatment success remains unclear. This study protocol outlines a multicenter, qualitative longitudinal study designed to explore how dynamic factors in DBT-A are experienced by adolescents, parents, and therapists at various stages of therapy. The study will track treatment journeys (trajectories) of fifteen youth during DBT-A therapy across four child and adolescent psychiatry institutions in the Netherlands. The triad of adolescent, parent(s), and therapist will be interviewed separately at four time points during treatment: at the start and after three, six, and nine months (resulting in 180 interviews in total). The semi-structured interviews, based on a theoretical framework, will be analyzed using reflexive thematic analysis, employing a combination of deductive framework analysis and inductive open coding methods. By bringing together the triad of perspectives, and monitoring how these perspectives evolve over time, this study will yield valuable, practice-based insights into how dynamic factors unfold during DBT-A. Insights from this study will offer therapists specific, actionable guidance for modifying dynamic factors to better address the unique needs of adolescents with BPD features.
Open AccessUnraveling dynamic factors in Dialectic Behavioural Treatment for Adolescents (DBT-A): a study protocol
Dialectical Behavioural Therapy for Adolescents (DBT-A) is an effective treatment for adolescents exhibiting features of borderline personality disorder (BPD). However, some do not benefit, potentially leading to major negative outcomes later in life. Previous quantitative studies have highlighted the importance of dynamic (changeable) factors in determining treatment success, including the therapeutic alliance, emotional dynamics between therapist and adolescent, and the motivation of those involved. Nevertheless, the specific contribution of these factors to the therapeutic process and perceived treatment success remains unclear. This study protocol outlines a multicenter, qualitative longitudinal study designed to explore how dynamic factors in DBT-A are experienced by adolescents, parents, and therapists at various stages of therapy. The study will track treatment journeys (trajectories) of fifteen youth during DBT-A therapy across four child and adolescent psychiatry institutions in the Netherlands. The triad of adolescent, parent(s), and therapist will be interviewed separately at four time points during treatment: at the start and after three, six, and nine months (resulting in 180 interviews in total). The semi-structured interviews, based on a theoretical framework, will be analyzed using reflexive thematic analysis, employing a combination of deductive framework analysis and inductive open coding methods. By bringing together the triad of perspectives, and monitoring how these perspectives evolve over time, this study will yield valuable, practice-based insights into how dynamic factors unfold during DBT-A. Insights from this study will offer therapists specific, actionable guidance for modifying dynamic factors to better address the unique needs of adolescents with BPD features.
- Open Access
- 22 August 2017
- Published by American Society of Hematology in Blood Advances
- Vol. 1 (19) , 1598-1616
Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review
Sickle-cell disease (SCD) is characterized by frequent and painful vaso-occlusive crises (VOCs). Various treatments have been evaluated over the years. However, a clear overview is lacking. The objective of this study was to systematically review all pharmacotherapeutical strategies in the prevention of VOCs beyond hydroxyurea. We performed a systematic literature search (MEDLINE, Embase, CENTRAL). Eligible studies were controlled clinical trials evaluating pharmacotherapeutical interventions targeting the reduction of VOCs in patients with SCD. Primary outcomes were the number or duration of SCD-related pain days, VOCs, or hospital admissions for VOCs. Secondary outcomes included time to first VOC or hospital admission for a VOC. A standardized data extraction sheet was used. The methodological quality of studies was assessed using Cochrane’s risk-of-bias tool. A total of 36 studies were included in this review, covering 26 different prophylactic interventions. The most promising interventions for reducing the frequency of either VOCs or hospitalizations were the oral antioxidants l-glutamine and ω-3 fatty acids and the IV antiadhesive agent crizanlizumab. Twenty-three studies did not show any beneficial effect of the intervention under investigation, and 6 studies were either too small or methodologically inadequate to draw conclusions. Because of the heterogeneity of interventions, no meta-analysis was performed. In conclusion, this review identified 3 promising pharmacotherapeutical strategies in the prevention of VOCs in SCD. Importantly, this study highlights the discrepancy between the significant burden of SCD worldwide and the low number of adequate trials performed. This review was registered at PROSPERO (CRD42015025250).
- 22 August 2017
- Published by American Society of Hematology in Blood Advances
- Vol. 1 (19) , 1598-1616
Open AccessPharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review
Sickle-cell disease (SCD) is characterized by frequent and painful vaso-occlusive crises (VOCs). Various treatments have been evaluated over the years. However, a clear overview is lacking. The objective of this study was to systematically review all pharmacotherapeutical strategies in the prevention of VOCs beyond hydroxyurea. We performed a systematic literature search (MEDLINE, Embase, CENTRAL). Eligible studies were controlled clinical trials evaluating pharmacotherapeutical interventions targeting the reduction of VOCs in patients with SCD. Primary outcomes were the number or duration of SCD-related pain days, VOCs, or hospital admissions for VOCs. Secondary outcomes included time to first VOC or hospital admission for a VOC. A standardized data extraction sheet was used. The methodological quality of studies was assessed using Cochrane’s risk-of-bias tool. A total of 36 studies were included in this review, covering 26 different prophylactic interventions. The most promising interventions for reducing the frequency of either VOCs or hospitalizations were the oral antioxidants l-glutamine and ω-3 fatty acids and the IV antiadhesive agent crizanlizumab. Twenty-three studies did not show any beneficial effect of the intervention under investigation, and 6 studies were either too small or methodologically inadequate to draw conclusions. Because of the heterogeneity of interventions, no meta-analysis was performed. In conclusion, this review identified 3 promising pharmacotherapeutical strategies in the prevention of VOCs in SCD. Importantly, this study highlights the discrepancy between the significant burden of SCD worldwide and the low number of adequate trials performed. This review was registered at PROSPERO (CRD42015025250).
- Open Access
- 1 July 2017
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 15 (7) , 1392-1402
Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state
- 1 July 2017
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 15 (7) , 1392-1402
Open AccessDynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state
- Open Access
- 23 June 2017
- Published by Wiley in British Journal of Haematology
- Vol. 182 (3) , 444-448
Effect of N‐acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial
- 23 June 2017
- Published by Wiley in British Journal of Haematology
- Vol. 182 (3) , 444-448
Open AccessEffect of N‐acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial
- 1 June 2013
- Published by Springer Nature in Tijdschrift voor kindergeneeskunde
- Vol. 81 (3) , 64-69
Implementatie van evidence-based medicine in de dagelijkse praktijk
- 1 June 2013
- Published by Springer Nature in Tijdschrift voor kindergeneeskunde
- Vol. 81 (3) , 64-69
Implementatie van evidence-based medicine in de dagelijkse praktijk